BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND KMT2D, ENSG00000167548, 8085, MLL2 AND Treatment
10 results:

  • 1. Comprehensive genomic profiling to identify actionable alterations for breast cancer brain metastases in the Chinese population.
    Lu Q; Wang N; Jiang K; Zhou H; Zhang P; Zhang J; Wang S; Sun P; Xu F
    ESMO Open; 2024 Mar; 9(3):102389. PubMed ID: 38460250
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survival.
    Ozyerli-Goknar E; Kala EY; Aksu AC; Bulut I; Cingöz A; Nizamuddin S; Biniossek M; Seker-Polat F; Morova T; Aztekin C; Kung SHY; Syed H; Tuncbag N; Gönen M; Philpott M; Cribbs AP; Acilan C; Lack NA; Onder TT; Timmers HTM; Bagci-Onder T
    Cell Commun Signal; 2023 Nov; 21(1):328. PubMed ID: 37974198
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Prognostic significance of Naples prognostic score in non-small-cell lung cancer patients with brain metastases.
    Xuan J; Peng J; Wang S; Cai Y
    Future Oncol; 2022 Apr; 18(13):1545-1555. PubMed ID: 35107367
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Histone Mark Profiling in Pediatric Astrocytomas Reveals Prognostic Significance of H3K9 Trimethylation and Histone Methyltransferase SUV39H1.
    Klonou A; Korkolopoulou P; Gargalionis AN; Kanakoglou DS; Katifelis H; Gazouli M; Chlamydas S; Mitsios A; Kalamatianos T; Stranjalis G; Themistocleous MS; Papavassiliou KA; Sgouros S; Papavassiliou AG; Piperi C
    Neurotherapeutics; 2021 Jul; 18(3):2073-2090. PubMed ID: 34296393
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Management of Very Late Pancreatic Metastasis of Renal Cell Carcinoma 8 Years After Radical Nephrectomy: A Report of a Rare Case.
    Alayyaf N; AlQatari AA; Altalib A; AlQattan AS; Alshahrani AA
    Am J Case Rep; 2021 Jan; 22():e927921. PubMed ID: 33400693
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Clinical and mutational profiles of adult medulloblastoma groups.
    Wong GC; Li KK; Wang WW; Liu AP; Huang QJ; Chan AK; Poon MF; Chung NY; Wong QH; Chen H; Chan DTM; Liu XZ; Mao Y; Zhang ZY; Shi ZF; Ng HK
    Acta Neuropathol Commun; 2020 Nov; 8(1):191. PubMed ID: 33172502
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Radiotherapy of non-small-cell lung cancer in the era of EGFR gene mutations and EGF receptor tyrosine kinase inhibitors.
    Moschini I; Dell'Anna C; Losardo PL; Bordi P; D'Abbiero N; Tiseo M
    Future Oncol; 2015; 11(16):2329-42. PubMed ID: 26260811
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Dissecting the genomic complexity underlying medulloblastoma.
    Jones DT; Jäger N; Kool M; Zichner T; Hutter B; Sultan M; Cho YJ; Pugh TJ; Hovestadt V; Stütz AM; Rausch T; Warnatz HJ; Ryzhova M; Bender S; Sturm D; Pleier S; Cin H; Pfaff E; Sieber L; Wittmann A; Remke M; Witt H; Hutter S; Tzaridis T; Weischenfeldt J; Raeder B; Avci M; Amstislavskiy V; Zapatka M; Weber UD; Wang Q; Lasitschka B; Bartholomae CC; Schmidt M; von Kalle C; Ast V; Lawerenz C; Eils J; Kabbe R; Benes V; van Sluis P; Koster J; Volckmann R; Shih D; Betts MJ; Russell RB; Coco S; Tonini GP; Schüller U; Hans V; Graf N; Kim YJ; Monoranu C; Roggendorf W; Unterberg A; Herold-Mende C; Milde T; Kulozik AE; von Deimling A; Witt O; Maass E; Rössler J; Ebinger M; Schuhmann MU; Frühwald MC; Hasselblatt M; Jabado N; Rutkowski S; von Bueren AO; Williamson D; Clifford SC; McCabe MG; Collins VP; Wolf S; Wiemann S; Lehrach H; Brors B; Scheurlen W; Felsberg J; Reifenberger G; Northcott PA; Taylor MD; Meyerson M; Pomeroy SL; Yaspo ML; Korbel JO; Korshunov A; Eils R; Pfister SM; Lichter P
    Nature; 2012 Aug; 488(7409):100-5. PubMed ID: 22832583
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Cooperative regulation of non-small cell lung carcinoma by nicotinic and beta-adrenergic receptors: a novel target for intervention.
    Al-Wadei HA; Al-Wadei MH; Schuller HM
    PLoS One; 2012; 7(1):e29915. PubMed ID: 22253823
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Combined modality therapy of lung cancer.
    Livingston RB
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2638-47. PubMed ID: 10068267
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.